Literature DB >> 29169991

Progression of Type 2 Helper T Cell-Type Inflammation and Airway Remodeling in a Rodent Model of Naturally Acquired Subclinical Primary Pneumocystis Infection.

Pablo A Iturra1, Diego A Rojas1, Francisco J Pérez1, Andrea Méndez1, Carolina A Ponce1, Paula Bonilla1, Rebeca Bustamante1, Héctor Rodríguez2, Caroll J Beltrán3, Sergio L Vargas4.   

Abstract

Subclinical primary Pneumocystis infection is the most common pulmonary infection in early infancy, making it important to determine whether it damages the lung. Pneumocystis peaks at 2 to 5 months of age, when respiratory morbidity coincidently increases. We have documented that Pneumocystis increases mucus production in infant lungs, and animal models reveal lung lesions that warrant characterization. Herein, immunocompetent rats infected at birth with Pneumocystis by cohabitation, to resemble community-acquired infection, underwent lung assessments at 45, 60, and 75 days of age. Lungs fixed by vascular perfusion to prevent collapse during necropsy were used for morphometry evaluations of mucus production, airway epithelial thickening, perivascular and peribronchiolar inflammation, and structural airway remodeling. Changes in these histologic features indicate lung disease. Selected immune markers were assessed in parallel using fresh-frozen lung tissue from sibling rats of the same cages. Sequential activation of NF-κB and an increased Gata3/T-bet mRNA level ratio, consistent with a type 2 helper T-cell-type inflammatory response, and subacute fibrosis were recognized. Therefore, documenting subclinical Pneumocystis infection induces lung disease in the immunocompetent host. Taken together with the peak age of primary Pneumocystis infection, results warrant investigating the clinical impact of this often subclinical infection on the severity of respiratory diseases in early infancy. This model can also be used to assess the effects of airway insults, including coinfections by recognized respiratory pathogens.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29169991     DOI: 10.1016/j.ajpath.2017.10.019

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  3 in total

1.  The association of trimethoprim-sulfamethoxazole with improved lung function in pediatric asthma.

Authors:  Taylor Eddens; Rachel Wolfe; Andrew Nowalk; Erick Forno; Brian T Campfield
Journal:  Ann Allergy Asthma Immunol       Date:  2021-01-17       Impact factor: 6.347

2.  Increase in secreted airway mucins and partial Muc5b STAT6/FoxA2 regulation during Pneumocystis primary infection.

Authors:  Diego A Rojas; Pablo A Iturra; Andrea Méndez; Carolina A Ponce; Rebeca Bustamante; Miriam Gallo; Pamela Bórquez; Sergio L Vargas
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

3.  Molecular detection of Pneumocystis in the lungs of cats.

Authors:  Patrizia Danesi; Michela Corrò; Christian Falcaro; Antonio Carminato; Tommaso Furlanello; Monia Cocchi; Mark B Krockenberger; Wieland Meyer; Gioia Capelli; Richard Malik
Journal:  Med Mycol       Date:  2019-10-01       Impact factor: 4.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.